Advances in Coronary Artery Disease

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 28 August 2024 | Viewed by 563

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cardiology, Santa Chiara Hospital, APSS, Trento, Italy
Interests: acute coronary syndromes; spontaneous coronary artery dissection; MINOCA

E-Mail Website
Guest Editor
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Interests: complex coronary interventions; chronic total occlusions; mechanical circulatory support

Special Issue Information

Dear Colleagues,

Despite continuous improvements in the diagnostic and therapeutic options, coronary artery disease (CAD) remains one of the most important causes of mortality and morbidity worldwide, with different manifestations, like acute coronary syndromes (ACSs), chronic coronary syndromes (CCSs), and myocardial infarction with non-obstructive coronary artery disease (MINOCA). Information about physiology, diagnosis, and treatment strategies is required to pursue precision medicine in the field and improve the prognosis of these patients. This Special Issue welcomes submissions about the topic of CAD, from basic science to clinical data, including case reports, original research, and state-of-the-art reviews.

We look forward to your submissions!

Dr. Filippo Zilio
Dr. Jose M Montero-Cabezas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery disease
  • acute coronary syndromes
  • chronic coronary syndromes
  • myocardial infarction with non-obstructive coronary artery disease
  • spontaneous coronary artery dissection
  • myocardial infarction
  • coronary physiology
  • multimodality imaging

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 2076 KiB  
Article
Drug-Eluting Balloons in Calcified Coronary Lesions: A Meta-Analysis of Clinical and Angiographic Outcomes
by Borja Rivero-Santana, Alfonso Jurado-Roman, Guillermo Galeote, Santiago Jimenez-Valero, Ariana Gonzalvez, Daniel Tebar and Raul Moreno
J. Clin. Med. 2024, 13(10), 2779; https://doi.org/10.3390/jcm13102779 - 9 May 2024
Viewed by 402
Abstract
Background: The usefulness of drug-eluting balloons (DEBs) has not been fully elucidated in calcified coronary lesions (CCLs). This meta-analysis aimed to evaluate the efficacy of DEBs compared to a drug-eluting stent (DES) in this setting. Methods: PubMed, EMBASE and Cochrane were searched through [...] Read more.
Background: The usefulness of drug-eluting balloons (DEBs) has not been fully elucidated in calcified coronary lesions (CCLs). This meta-analysis aimed to evaluate the efficacy of DEBs compared to a drug-eluting stent (DES) in this setting. Methods: PubMed, EMBASE and Cochrane were searched through December 2023. The primary endpoint was 12 months major adverse cardiac events (MACE). Secondary endpoints included clinical outcomes and angiographic results after PCI and at a 12-month follow-up. Results: Five studies and a total of 1141 patients with 1176 coronary lesions were included. Overall, the DEB was comparable to DES in MACE (RR = 0.86, 95% CI: 0.62–1.19, p = 0.36), cardiac death (RR = 0.59, 95% CI: 0.23–1.53, p = 0.28), myocardial infarction (RR = 0.89, 95% CI: 0.25–3.24, p = 0.87) and target lesion revascularization (RR = 1.1, 95% CI: 0.68–1.77, p = 0.70). Although the DEB was associated with worse acute angiographic outcomes (acute gain; MD = −0.65, 95% CI: −0.73, −0.56 and minimal lumen diameter; MD = −0.75, 95% CI: −0.89, −0.61), it showed better results at 12 months follow-up (late lumen loss; MD = −0.34, 95% CI: −0.62, −0.07). Conclusions: This meta-analysis showed that the DEB strategy is comparable to DES in the treatment of CCLs in terms of clinical outcomes. Although the DEB strategy had inferior acute angiographic results, it may offer better angiographic results at follow-up. Full article
(This article belongs to the Special Issue Advances in Coronary Artery Disease)
Show Figures

Figure 1

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Clinical outcomes and current percutaneous treatment strategies for coronary calcified nodules: a systematic review and meta-analysis

Back to TopTop